A number of methods are used for the measurement of plasma fibrinogen (Tocantins and Kazal, 1964) . These include (1) the estimation of clottable or precipitable protein by gravimetric or colorimetric means; (2) the thrombin clotting time using the time of clot formation as the endpoint (Vermylen, Verstraete, and de Vreker, 1963) or the maximum dilution at which a clot appears as the endpoint (Schneider, 1952) ; and (3) immunological assays using tanned red cell (Fox, Wide, Killander, and Gemzell, 1965) or a latex-bound antihuman fibrinogen antibody (Fi test) .
Assays based on the clottable protein estimation are accurate but time-consuming and thus have diagnostic limitations in acquired haemorrhagic disorders with suspected --cute hypofibrinogenaemia. Methods based on the thrombin clotting time are simple and rapid; however, previous investigations have shown that this assay is markedly inhibited by the presence of fibrinogen breakdown products (Hirsh, Fletcher, and Sherry, 1965 ). An immunological method, the latex-bound antihuman fibrinogen test (Hyland, U.S.A.), has been available as a semiquantitative fibrinogen assay for a number of years, and more recently it has been used as a quantitative assay of plasma fibrinogen (Zucker, Pert, and Hilgartner, 1966) . Although fibrinogen breakdown products have been show'n to react with the Fi reagent (Hirsh et al, 1965) Blomback and Blomback, 1956) was kindly supplied by the Commonwealth Serum Laboratories, Victoria, and was found to be 90% clottable. This preparation of fibrinogen was used to prepare antibodies as previously described (Hirsh et al, 1965) . The fibrinogen antiserum was adsorbed with lyophilized human serum and produced a single band when reacted by immunodiffusion with human fibrinogen and plasma, but failed to react with human serum. Plasmin (A. B. Kabi and Co., Stockholm) was dissolved in distilled water to a concentration of 5 casein units (cu) per ml and stored at -20°C. Topical thrombin (Parke Davis) dissolved in 50% glycerol in 0 9% NaCI at a concentration of 1,000 units per ml was stored at -20'C, and diluted immediately before use. Soybean trypsin inhibitor (Worthington Biochem. Co., U.S.A.) was stored at 4°C. The serum used to prepare fibrinogen samples was inactivated to eliminate thrombin activity by heating at 56'C for 30 minutes. immediately after clotting and lysis was inhibited at two hours (early fibrin breakdown products) and 24 hours (late fibrin breakdown products) by the addition of soybean trypsin inhibitor. The inactivation of the plasmin was confirmed by fibrin plate assay.
IMMUNOLOGICAL
TECHNIQUES Immunoelectrophoresis was performed as described by Crowle (1961) using a micromethod and 1% agar (lonagar no. 2, Oxoid Consolidated Laboratories, Inc., Chicago Heights, Ill.) in barbital buffer, pH 8-6, ionic strength 0-05. Electrophoretic separation was performed in barbital buffer, pH 8-6, ionic strength 0 5, using a Shandon apparatus at 90 V for 2 hr and voltage control.
PATIENT STUJDIES Venous blood from patients and controls was collected in siliconized 20 ml syringes and mixed with 3 8 % trisodium citrate in the ratio of 9 parts of blood to 1 part of anticoagulant. The blood was centrifuged at 3,000 g for 15 minutes and the platelet-poor plasma separated and tested.
ASSAY OF FIBRINOGEN
The modified Fi test Preliminary attempts were made to quantitate the Fi test using plasma which was serially diluted until agglutination failed to occur. This technique proved unsatisfactory because it was necessary to dilute the plasma to approximately 1 in 10,000 to eliminate agglutination. At these high dilutions the endpoint was difficult to establish because the clumps were small and poorly defined. The assay was therefore performed using the agglutination time rather than the presence of agglutination as the endpoint. A plasma sample of known fibrinogen level was serially diluted in heat-inactivated serum. Each of the samples was further diluted 1/200 and 1/1,000 in borate buffer and standard curves were obtained for both dilutions. From these two standard curves it was possible to establish a range of fibrinogen concentrations from 40 to 400 mg% (Fig. 1) . The 1/200 dilution curve gave more accurate results for low fibrinogen concentrations but fibrinogen concentrations above 200 mg% could only be adequately quantitated using the 1/1,000 dilution curve.
A Alkjaersig, Fletcher, and Sherry (1959) .
Thrombin time assay offibrinogen The thrombin time was performed as previously described (Alkjaersig et al, 1959) . A standard curve (Fig. 2) 
IMMUNOELECTROPHORESIS OF BREAKDOWN PRODUCTS
Immunoelectrophoresis of fibrinogen and the early and late fibrinogen and fibrin breakdown products is shown in Figure 5 . The preparations were reacted with fibrinogen antiserum. Fibrinogen is seen as a single precipitin line, the early fibrinogen breakdown products as two components with similar electrophoretic mobility, the early fibrin breakdown products as a distinct precipitin line and a less distinct component, and the late breakdown products of both fibrinogen and fibrin as two widely separated components. ever, only two of the four types of breakdown products appeared to react with the Fi reagent. The early fibrin breakdown products agglutinated the Fi reagent in a similar manner to fibrinogen, while the early fibrinogen breakdown products did not produce macroscopic agglutination but interfered with fibrinogen-induced agglutination. In contrast, the late products of both fibrinogen and fibrin breakdown neither agglutinated the Fi reagent nor appeared to interfere with fibrinogen-induced agglutination. It is likely that the immunoreactivity with the Fi reagent of fibrinogen and the breakdown products of fibrinogen and fibrin is related to the size and the number of antigenically active sites on the individual particles and that all four types of breakdown products react with the Fi reagent but that the late products, because of their relatively small size, are unable to agglutinate the Fi reagent.
Immunoassay of serum for fibrinogen and fibrin breakdown products has been used as a method for assessing plasma fibrinolytic activity (Merskey, Kleiner, and Johnson, 1966) . 
